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Abstract
Background: Hazard ratios are ubiquitously used in time to event applications to quantify adjusted covariate effects.
Although hazard ratios are invaluable for hypothesis testing, other adjusted measures of association, both relative and
absolute, should be provided to fully appreciate studies results. The corrected group prognosis method is generally
used to estimate the absolute risk reduction and the number needed to be treated for categorical covariates.
Methods: The goal of this paper is to present transformation models for time-to-event outcomes to obtain, directly
from estimated coefficients, the measures of association widely used in biostatistics together with their confidence
interval. Pseudo-values are used for a practical estimation of transformation models.
Results: Using the regression model estimated through pseudo-values with suitable link functions, relative risks, risk
differences and the number needed to treat, are obtained together with their confidence intervals. One example based
on literature data and one original application to the study of prognostic factors in primary retroperitoneal soft tissue
sarcomas are presented. A simulation study is used to show some properties of the different estimation methods.
Conclusions: Clinically useful measures of treatment or exposure effect are widely available in epidemiology. When
time to event outcomes are present, the analysis is performed generally resorting to predicted values from Cox
regression model. It is now possible to resort to more general regression models, adopting suitable link functions and
pseudo values for estimation, to obtain alternative measures of effect directly from regression coefficients together
with their confidence interval. This may be especially useful when, in presence of time dependent covariate effects, it
is not straightforward to specify the correct, if any, time dependent functional form. The method can easily be
implemented with standard software.
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Background
Measures of disease frequency and measures of associ-
ations derived from them are among the basic building
blocks of biostatistics and epidemiology. The appropri-
ateness of the use of a specific measure of association
may depend on the study objectives and design. Some-
times, however, the use of specific measures of association
depends also on the statistical methods available for esti-
mation. For example, in epidemiology, a debated subject
concerns the use of odds ratios, estimated through logistic
regression, in cohort studies of common outcomes [1,2].
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When time-to-event outcomes are analyzed, the pres-
ence of censoring calls for specific methods of analysis
[3]. The evaluation of the effect of a treatment in a con-
trolled trial can be performed through the graphical dis-
play and comparison of Kaplan-Meier curves at selected
times, when adjustment is not required. Otherwise, the
measure of effect generally considered is the adjusted haz-
ard ratio estimated by means of Cox proportional hazard
model, ([4,5]).
However, the clinical literature in randomized con-
trolled trials suggests the use of absolute measures of
effect to assess the effects of a treatment, such as risk dif-
ference or the number needed to be treated, which are
better suited than relative measures of effect for clinical
decision support, see [6-10] among others. Schechtman
highlights how relative measures are appropriate for
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summarizing the evidence while absolutemeasures for the
concrete application in a clinical setting, [11].
The need for alternatives to hazard ratios, a relative
measure of effect based on (instantaneous) incidence
rates, is increasing in medical/epidemiological literature.
In particular, the possibility to provide absolute measures
of association computed using adjusted survival curves
was explored in literature [12-14].
To precisely define the different measures of association
in time-to-event applications, it is useful to distinguish
between the risk of the event, F(t), i.e. the probability of
a patient having the event over a defined follow-up time,
and the event rate, λ(t), i.e. the number of events in a
specified follow-up interval divided by the time at risk
accumulated during the interval. The instantaneous haz-
ard rate is obtained when the interval length approaches 0.
The hazard rate at time t refers to the population survived
until time t, while the risk refers to the whole population.
The measures considered in this paper refer to ratios and
differences between the risk of event of different groups
of subjects. Let F1(t) and F2(t) be the event risk by t in
two groups of subjects, (exposed and non exposed, stan-
dard treatment and new treatment), then we define the
risk difference as RD(t) = F1(t) − F2(t). It is useful to
translate RD(t) expressed as a percentage measure in a
measure more sensible form a clinical perspective. To this
end it is usual to use the number needed to be treated
NNT(t) = 1/RD(t) which is interpreted as the expected
number of patients needed to be treated to avoid one
additional death compared to the untreated. The measure
has its roots in clinical trial literature and was extended
in an epidemiological framework as the number needed
to be exposed, NNE(t), i.e. the expected number of sub-
jects to be exposed to have one additional event compared
to the unexposed. In observational studies, an alterna-
tive definition of NNE(t) is the exposure effect among the
unexposed, while the exposure impact number, EIN(t),
describes the effect of removing the exposure among the
exposed [15-17]. It is also interesting to define a relative
risk, RR(t) = F1(t)F2(t) , to be contrasted with the hazard ratio,
HR(t) = λ1(t)
λ2(t) . The different measures of effect are in gen-
eral time-varying. In certain situations, however, they are
estimated as constant through follow-up, as it happens for
example with the Cox proportional hazard model for the
hazard ratio. When the measure is assumed to be con-
stant during follow-up the time dependence is omitted
(i.e., HR(t) is written as HR).
The purpose of this paper is to provide an outline
of the methods generally adopted to estimate adjusted
summary measures of associations, different from the
hazard ratio, in time-to-event studies and to present
a new method based on transformation models. The
focus of this paper is not to provide guidance about
which association measure should be used in different
situations, but simply to provide an estimation method.
Moreover, particular attention will be given to the esti-
mate of adjusted RD(t). In fact, absolute measures of
association are particularly advocated in survival analysis,
to be combined with the generally used hazard ratio. A
small simulation study is provided to show a preliminary
evaluation of the properties of the different estimation
procedures. Two examples are then developed. The first
concerns literature data on a clinical trial on 506 prostate
cancer patients [18]. The goal is to estimate the treat-
ment RD(t) and NNT(t) with their confidence intervals.
A comparison of the model based estimated RD(t) with
that obtained with the classical corrected group prognosis
method [14] is provided. The second application concerns
an observational study of prognostic factors in primary
retroperitoneal soft tissue sarcomas [19].
Methods
Computation of association measures
In many situations a researcher is interested in pro-
viding adjusted estimates of covariate associations with
the outcome. In observational studies (involving no ran-
domization) the exposure effect has to be adjusted for
known confounders. Also in randomized controlled tri-
als (RCT) the use of adjusted estimates is suggested for
example to account for potential covariate imbalances or
since prognostically relevant covariates were considered
for a stratified randomization [20-22]. In these cases, Cox
regression is widely used to adjust the estimated associa-
tion between the covariate of interest and outcome for the
other covariates.
For the purpose of illustration, let us consider a con-
trolled trial, where the event of interest is death, inves-
tigating the efficacy of a new treatment (T = 1) in
comparison to a standard treatment (T = 0). Two covari-
ates such as age, A, and gender, G, are considered for
adjustment. The multivariable proportional hazard Cox
model can be specified as follows:
λ(t|T ,A,G) = λ0(t) exp(αT + βA + γG)
where t is the time to event; λ(t|T ,A,G) is the hazard
function conditional to covariate values; α, β and γ are
the regression coefficients; λ0(t) is the baseline hazard
for a subject in the control group (T = 0), 0 years old
and female (G = 0). The adjusted hazard ratio for the
treatment, HR constant through follow-uptime, is simply
obtained as exp(α). Using such a model, RD(t) or NNT(t)
for the treatment can be obtained specifying a covariate
pattern and the baseline risk. For example, the estimated
NNT(t), conditional on being male 40 years old is:
1
Sˆ(t|T = 1,A = 40,G = 1) − Sˆ(t|T = 0,A = 40,G = 1) .
(1)
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where Sˆ(t|T = 1,A = 40,G = 1) is the estimated survival
probability for a male 40 years old in the experimen-
tal treatment group, given by [Sˆ0(t)]exp(αˆ+βˆ 40+γˆ ), while
Sˆ(t|T = 0,A = 40,G = 1) is the estimated survival prob-
ability for a male 40 years old, in the control group, given
by [Sˆ0(t)]exp(βˆ 40+γˆ ). Sˆ0(t) is the baseline survivor func-
tion from a Cox proportional hazards model estimated
according to one of the available methods [23,24].
In order to obtain adjusted measures of association, dif-
ferent from the hazard ratio, the Cox proportional hazard
model is used to estimate adjusted survival curves [25] as
outlined in the following paragraphs.
Average covariate method
The simplest approach for obtaining adjusted survival
curves is the average covariate method. The mean val-
ues among the study patients of the covariates used for
adjustment are plugged into the multivariable Cox pro-
portional hazard model. Considering the above example,
if themean age of subjects in study is 45 and 30%males are
included, the adjusted ˆNNT(t) for the treatment will be
1
Sˆ(t|T=1,A=45,G=0.3)−Sˆ(t|T=0,A=45,G=0.3) . The average covari-
ate method was once popular and largely adopted, due to
its simplicity, but it was severely criticized [25,26].
In fact it involves the averaging of categorical covariates,
such as gender, which is difficult to understand. More-
over the method provides an estimate of the measure of
effect for an hypothetical average individual and not a
population averaged estimate.
Corrected group prognosis method and developments
An alternative idea is the corrected group progno-
sis method (CGPM), [14,27,28]. In the following, the
CGPM to estimate RD(t), as described by Austin [14], is
outlined:
• AMultivariable Cox (or fully parametric) regression
is used for the treatment and the covariates.
• For each subject, the predicted survival probabilities,
at the times of interest, are estimated using the
multivariable model, assuming each subject is in the
experimental treatment group; then the predictions
are averaged;
• the same predictions are obtained and averaged
assuming each subject is in the control group.
• the difference between the averaged predicted
probabilities between experimental and control
group is an estimate of the adjusted RD(t) for the
experimental treatment at the specified times.
Pointwise confidence intervals of the obtained RD(t)
estimates may be computed via bootstrap resampling [14].
For each bootstrap sample, i.e. a sample of the same size
of the original one and randomly drawn with replacement
from it, the RD(t) is computed according to the procedure
outlined. A non parametric bootstrap 95% pointwise
confidence interval is obtained resorting to the 2.5th
and 97.5th percentiles of the obtained RD(t) bootstrap
distribution.
A simulated example of the estimation of RD(t) in
presence of confounding is exemplified in Figure 1.
The CGPM can be applied in principle to whatever
regression model and an adequate model must be cho-
sen. Considering, for example, the Cox regression model,
in presence of time dependent covariate effects, an
interaction of the covariates with a pre-specified func-
tion of time should be specified, in order to estimate
HR(t) varying during follow-up time. It is important to
remark that it is not always easy to specify an adequate
model in presence of time dependent covariate effects.
In fact it is not always obvious how to model the time
dependence itself. In general simple functions of time
(linear or logarithm) or more flexible alternatives are
used, [29].
To allow the estimation the data set must be augmented
as it is done for true time-dependent covariates [30]. It
is to be remarked that, although the use of predicted
values from regression models is simple from a practi-
cal point of view, the standard way to obtain summary
measures of effect and their confidence interval is to
use directly regression model coefficient estimates. The
CGPM applied to the Cox model will be used for compar-
ison with the method here proposed and described in the
following section.
Laubender and Bender, [13], proposed different aver-
aging techniques to estimate relevant impact numbers
in observational studies using Cox model. For the pur-
pose of illustration, let us consider the same example
as before simply considering an exposure (E) instead of
treatment. To obtain an estimate of NNE(t) it is possi-
ble to average predictions considering the subjects as if
they were unexposed and as if they were exposed and
taking the difference. As the distributions of the covari-
ates used for adjusting are in general different in the
exposed and unexposed groups, two different measures
should be considered. Specifically, the estimate of the
NNE(t) is obtained considering the unexposed subjects
only, while EIN(t) is obtained considering the exposed
subjects only. A comparison of the model based esti-
mated RD(t) with that obtained through different aver-
aging techniques, namely NNE(t) and EIN(t) [13,15], is
provided in the second example. However, the focus of
the paper is not the comparison of different averaging
techniques which are provided only for illustrative pur-
poses. In particular, only the estimates obtained through
the averaging performed over the whole population are
compared with those based on transformation models
methods.
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Figure 1 Simulated data: RD(t) and Kaplan-Meier Curves. Estimation of RD(t) associated with an hypothetical experimental treatment using
artificial data simulated from a proportional hazard model (Details on the simulation are reported in the manuscript). The treatment effect is
confounded by two covariates. The unadjusted Kaplan-Meier survival probabilities (- - - -) are reported together with the adjusted estimates (—–)
obtained with the corrected group prognosis methods (left panel). The corresponding RD(t) estimates are reported in the right panel together with
the model based constant RD estimate (with confidence interval).
Model-based estimates of association measures
Adjusted model-based estimates of measures of associ-
ation can be obtained resorting to a general class of
regression models used in Survival Analysis called trans-
formation models [31].
Pseudo values
Considering the previous example, the transformation
model can be written as g(S(t|T ,A,G)) = g(S0(t))+αT+
βA + γG.
A possibility to estimate transformation models, using
standard available software, is through pseudo-values
[32]. The pseudo value is defined for each subject i at any
time t and is given by
θˆi(t) = nSˆ(t) − (n − 1)Sˆ−i(t) (2)
where n is the sample size, Sˆ(t) is the survival probabil-
ity based on the Kaplan-Meier estimator using the whole
sample and Sˆ−i(t) is the survival probability obtained by
deleting the i subject from the sample. When no censor-
ing is present in the data, the pseudo values for subject i
at time t is simply 1 if the subject is alive at t, while it is
0 if the event happened by t. Suppose to have an exposed
male, 40 years old, which dies after 30 months of follow-
up. The pseudo values computed at 12, 24 and 36 months
are equal to 0, 0 and 1 respectively. The times at which the
pseudo-values are computed are called pseudo-times.
When censoring is present in the data, pseudo-values
are still defined for each subject (even those censored) and
for each time, but the values may also be less than 0 or
greater than 1 (See [33]; page 5310–11 for further details
on the properties of pseudo-values).
In general, to allow inference on the entire survival
curve, M (greater than 5) pseudo times are used, con-
sidering, for example, the quantiles of the unique failure
time distribution. As M pseudo values are computed for
each subject, an augmented data set is created with M
observations for each subject.
Transformationmodels and associationmeasures
The pseudo-values are then used as responses in a regres-
sionmodel for longitudinal data, where time is a covariate.
As no explicit likelihood is available for pseudo-values,
generalized estimating equations (GEE), [34], are used
accounting for the correlation of the pseudo-values within
each subject. The cluster robust variance-covariance is
used for hypothesis testing using Wald tests. In general
an independence working variance-covariance matrix can
conveniently be used in the estimation process [32].
In order to model g(S0(t)), the transformed baseline
survival function, the standard procedure is to insert in
the regression model indicator functions for each pseudo-
time. If all event times would be used to compute the
pseudo-values, the insertion of indicator functions would
result in a non parametric representation of the (trans-
formed) baseline survival, as in the Cox model. In general
only a small number of pseudo-times are used obtaining
a parametric baseline representation. As an alternative,
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spline functions can be inserted in the regression model,
as did [35] in a non-pseudo-values framework.
Considering for simplicity only two spline bases, the
regression model of the example can be written as follows:
g(θi(t)) = φ0 +φ1B1(t)+φ2B2(t)+αTi +βAi + γGi (3)
where B1(t) and B2(t) represent the first and second spline
bases for time t. For example, if a restricted cubic spline
basis is used with three knots at k1, k2, k3, then B1(t) = t
and B2(t) = (t − k1)3+ − (t−k2)
3+(t3−t1)
(t3−t2) +
(t−k3)3+(t2−t1)
(t3−t2) ,
where, for example, (t−k1)3+ is equal to (t−k1)3 if t > k1,
otherwise is 0. Knots are chosen at quantiles of the failure
time distribution. In the case of 3 knots the quantiles com-
monly suggested are 0.1, 0.5 and 0.9, [36]. To choose the
complexity of the spline the QIC, [37], an information cri-
terion proposed for generalized estimating equations, can
be used. A less formal strategy is the graphical comparison
between the Kaplan-Meier marginal survival probability
and the marginal probability obtained from the transfor-
mation model without covariates. Such a procedure will
be used in the examples.
The first part of the model, φ0 + φ1B1(t) + φ2B2(t),
provides a parametric representation of the (transformed)
baseline survival function, g(S0(t)), during follow-up
time.
The coefficients α, β and γ represent the covariate
effects expressed as differences in the Survival probabil-
ity, transformed by g associated with a unit increase in the
covariates. Let us consider such an issue in detail. When
g is the logit link function, a proportional odds model
is estimated. Accordingly, α, β and γ represent the log-
arithm of the ratio of the odds of surviving associated
with the change of one unit in the covariates. Such an
effect is constant through follow-up times. The exponen-
tiation of the parameter estimates represent therefore the
ratio of the odds of surviving. Similarly, the logarithmic
link produces a proportional risks model and the exp(α),
exp(β) and exp(γ ) represent the ratio of the survival prob-
abilities (Relative Risks, RR). The identity link produces
a constant survival difference model: α, β and γ repre-
sent the adjusted differences in survival probabilities (risk
differences, RD). A constant difference model through
follow-up is often not practical as a model such that at the
beginning of the follow-up the survival curves start at 1
and then, eventually, become different. However, it is to
be noted that the first pseudo-time is never placed at time
0, but later on the follow-up time scale. In Figure 1 an
example of the model based RD estimate with pointwise
confidence intervals, constant through time, is reported in
the right panel. The constant model estimated RD can be
used to obtain a constant estimate of NNT by inversion.
In the case of treatment T: ˆNNT =[ αˆ]−1. The value of 1
indicates the largest possible effect of NNT , while in cor-
respondence of no covariate effect (RD=0) the NNT value
is ±∞. The largest possible harmful effect is −1. Positive
and negative values of NNT represent the expected num-
ber of patients needed to be treated for one additional
patient to benefit and to be harmed, respectively.
In the case of the log-log link, g = log(−log(•)), exp(α),
exp(β) and exp(γ ) are the ratio between cumulative haz-
ard functions associated with the change of one unit in the
covariates. This ratio is equal to that of hazard functions,
only in the proportional hazard case.
The method allows to estimate the measures of effect
also for continuous covariates. For example, the evalua-
tion of a biomarker effect measured on a continuous scale,
without cutoffs, is still possible with this methodology.
The use of different link functions to obtain a particular
measure of effect, is an established technique in binomial
regression, where the use of non-canonical links, such
as the logarithm, allows to obtain adjusted measures of
impact different from the odds ratio, [1,38]. Wacholder,
[39], is an excellent reference for deepen such aspects in
the framework of logistic regression.
When there is evidence for time dependent effects of the
covariates, the interaction between the covariates and the
spline bases B1(t) and B2(t) are included in model (3).
g(θi(t)) = φ0 + φ1B1(t) + φ2B2(t) + αTi + βAi + γGi
+ γ1B1(t)Ti + γ2B2(t)Ti + γ3B1(t)Ai
+ γ4B2(t)Ai + γ5B1(t)Gi + γ6B2(t)Gi
In such a case, the estimated g-transformed survival
probability differences change during follow-up time. In
order to show the effect, varying in time, of a dichotomous
covariate, for example treatment T , it is useful to adopt a
graphical display, where the time is put on the horizontal
axis while the function exp(α + γ1B1(t) + γ2B2(t)) is on
the vertical axis (exponentiation is not used with the iden-
tity link; RD(t) = α + γ1B1(t) + γ2B2(t)). In this case the
estimated NNT(t) is naturally varying through follow-up
time and again obtain by inversion: RD(t)−1.
For a continuous covariate, such as Age, A in the exam-
ple, it is possible to use a surface plot, where Age and time
are on the x and y axis, while the z axis reports the covari-
ate effect with respect to a reference value. It would also be
possible tomodel Age effect with spline bases. In this case,
the interaction between Age and time is obtained through
tensor product spline bases of Age and time.
When a large number of pseudo-times is used, spline
functions allow to model parsimoniously the baseline
risk compared to indicator functions. This is particularly
important for the modelling of time-dependent effects
in connection to the different link functions. In princi-
ple when a covariate effect is constant using a specific
link, it should be time-varying with the other links. No
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statistical evidence against a constant covariate effect for
more than one link may only be due to lack of power. The
problem can also be exacerbated by some multiple testing
issue. Time-dependent effects selection depends therefore
on the link transformation used. As a consequence, the
adjusted effect of a covariate may be constant using a link
function, but time-dependent using a different link.
Moreover, the fitted values of the different models
selected for the different link functions are generally
different, being equal only if the models are saturated.
Traditionally, the strategy used in the application of trans-
formation models such as (3) was to select the best fitting
g transform, i.e., the transform where covariate effects
are constant through time, see [40,41] as examples. The
approach considered here is different. The interest is in
using the g-transform which is the most informative for
the clinical or biological counterpart. Generally the best
fitting link function and the one selected by the researcher
are not the same. Time dependent effects should therefore
be expected in the model.
Pointwise confidence intervals
Approximate pointwise 95% confidence intervals are cal-
culated from model results as in standard GLM/GEE
modelling. The computation is easy when covariate effects
are constant on the g-transformed scale. The cluster-
robust variance-covariance matrix must be used. Using
model (3) as example, the 95% CI for treatment, on the
transformed g scale, will be
llower , lupper = αˆ ± 1.96 × st.error(αˆ)
where st.error(αˆ) is the estimated cluster-robust standard
error for themodel parameter α. When g is the log, logit or
log− log link function, the 95% CI for the treatment effect
(respectively an RR, OR orHR) is [exp.(llower), exp(lupper)].
With the identity link, the 95% confidence intervals is
[llower , lupper], without additional transformations, and the
corresponding interval for NNT is [1/lupper , 1/llower].
A Clarification is necessary for the confidence interval
of the NNT.
When the estimated constant RD is not statistically sig-
nificant the confidence interval of RD includes 0. The
limits of the confidence interval are one positive and the
other negative. The resulting confidence interval forNNT
should include infinity (∞), [42]:
95%C.I. = [−∞, 1/llower] ∪
[
1/lupper ,+∞
]
With time-varying covariate effects, the variance of the
sum of a linear combination of different parameter esti-
mates must be computed for the each of the follow-up
times. For example, for treatment T , the variance of inter-
est, at a specific time t, is that of the linear combination
α+γ1B1(t)+γ2B2(t).Written inmatrix terms the variance
at time t is given by:
(
1 B1(t) B2(t)
) ( V (α) Cov(α, γ1) Cov(α, γ2)
Cov(α, γ1) V (γ1) Cov(γ1, γ2)
Cov(α, γ2) Cov(γ1, γ2) V (γ2)
) ( 1
B1(t)
B2(t)
)
where V (•) stands for the cluster-robust variance, while
Cov(•, •) stands for the cluster-robust covariance of two
random variables. When the variances at the different
times are calculated, the pointwise 95% CI can be com-
puted as before.
Software implementation
The approach to censored data regression based on
pseudo values was applied to regression models for the
cumulative incidence functions in competing risks and
for multi-state modeling [43], for the restricted mean [44]
and for the survival function at a fixed point in time
[45]. Implementation details and software can be found in
Klein et al., [32], and Andersen and Perme, [46].
Software is available to compute pseudo values (macro
%pseudosurv in SAS and function pseudosurv in
R package pseudo [32]) Standard GEE tools available
in SAS or R can be used for regression. In SAS the
proc genmod allows to change link functions using the
instructions FWDLINK and INVLINK. In R, the package
geepack can be conveniently used, see [32] for details.
As an example of the R software implementation, the
identity link is used:
geese( pseudo ~ rcs(tpseudo,3) + ....,
family = "gaussian", mean.link = "identity",
id = id, corstr="independence", data = b,
scale.fix=TRUE, scale.value=1 )
where the variable pseudo contains the pseudo values
and the variable tpseudo the pseudo-times according to
the software reported in [32]. The R function rcs of the
package rms, [47], is used to compute restricted cubic
spline bases. Each subject is represented by multiple rows
in the data, one for each pseudo time. The records for
each subject are identified by means of the variable id
which is used to estimate the robust standard error by
the geese function. Using the identity link function, the
estimated coefficients can be interpreted as the adjusted
RD(t) estimates.
Results
The estimation of RD(t) through pseudo-values is eval-
uated through a simple simulation study. Moreover, two
real examples are presented. The first example concerns a
prostate cancer trial, well known in competing risks liter-
ature, to show a situation where proportional hazard fail
to model the treatment effect during the whole follow-
up. The second example regards the analysis of prognostic
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factors in an observational study of primary retroperi-
toneal soft tissue sarcoma patients. R software, [48], was
used for the simulation and both the examples presented.
Simulation
Data are generated to simulate Cox regression model,
according to [13]. Suppose 100 persons are exposed
(Z = 1) and 100 unexposed (Z = 0). A confounder X is
generated normally distributed with mean 40 for Z = 0
and 45 for Z = 1 (standard deviations is 8 for both). Event
times are generated according to an exponential propor-
tional hazard model λ(t|X,Z) = λelog(1.01)X+log(1.80)∗Z .
Censoring times are obtained in the same way adjusting
the baseline hazard to have about 10% censoring. In such
a situation the true exposure RD(t) may be calculated
integrating out the covariate X:
∫ ∞
−∞
(S(t|Z = 1,X) f (X|Z = 1) − S(t|Z = 0,X)f (X|Z = 0))dx
(4)
Pointwise confidence intervals for the CGPM are cal-
culated using percentile bootstrap (200 bootstrap samples
for each simulated data set). RD(t) is estimated by trans-
formation models using pseudo values and the identity
link. The baseline cumulative risk is modelled using a
restricted cubic spline with 5 knots at 5%, 25%, 50%, 75%
and 95% quantiles of the failure time distribution. In the
pseudo valuemodel the Z covariate is inserted either with-
out and with an interaction with the baseline risk (i.e.
estimating a constant RD, and a time-dependent RD(t)
through follow-up time). The estimated RD and RD(t) at
times 200, 400 and 600 are collected and compared with
the true values. Such times are chosen to be sure that
they are between the first and the last pseudo-times in
all simulations. The results are analyzed in terms of bias,
root mean squared error, average length and coverage of
the 95% confidence intervals. The results are reported in
Table 1.
RD(t) estimated through the CGPM using the Cox pro-
portional hazard regression model (the model used to
generate the simulation data) is used as the benchmark
estimation method.
Themethod based on pseudo-values with Z time depen-
dent appears effective especially in terms of bias. Con-
fidence interval coverage is good, although the width of
the confidence intervals with pseudo-values is fairly large.
It is interesting to observe the results of pseudo-values
with the covariate Z not time dependent. In this case
the estimated risk difference is constant through time,
namely RD, a situation which can result from lack of
power to detect the time-dependence of the RD(t). The
simulation results appear very interesting for late follow-
up times. At time 600, results are very similar to that of the
Table 1 Event times generated according to a
Cox-exponential model with a confounder X and an
exposure status Z
BIAS
√
MSE
PV PV Cox PV PV Cox
(Z td) (Z const) CGPM (Z td) (Z const) CGPM
200 -0.0112 -0.0966 -0.0170 0.0756 0.1042 0.0580
400 -0.0047 -0.0681 -0.0145 0.0701 0.0785 0.0523
600 -0.0081 -0.0034 -0.0094 0.0528 0.0392 0.0376
Width Coverage
PV PV Cox PV PV Cox
(Z td) (Z const) CGPM (Z td) (Z const) CGPM
200 0.2857 0.1527 0.2143 0.9430 0.3150 0.9480
400 0.2791 0.1527 0.1926 0.9560 0.5830 0.9340
600 0.1949 0.1527 0.1418 0.9350 0.9400 0.9320
CGPMwas adopted using the Cox proportional hazard regression model. PV
model was adopted with identity link. Pseudo times were fixed at quantiles 5%,
25%, 50%, 75%, 95% of the failure time distribution. The Z covariate was inserted
in the PV model with an interaction with the baseline risk function modelled
with a restricted cubic spline with 3 knots (Z td) giving an estimated risk
difference varying through follow-up time, RD(t), and without time-dependence
to estimate a constant RD through follow-up time between the first and the last
pseudo-times (Z const).
Cox proportional model. However, the PV method with
identity link and without time dependence estimating a
constant RD leads to a strong undercoverage demon-
strating that the estimation of a constant RD may be
misleading.
The same simulation is performed generating times
from a Cox model with a time-dependent effect for
Z according to the following formula: λ(t|X,Z) =
λelog(1.01)X−log(0.95)∗Z∗log(t). In this second simulation the
Cox model used with CGPM iss specified in two differ-
ent ways. Specifically, the covariate Z is inserted with
an interaction with log(t), the correct one, and with a
restricted cubic spline of time with 3 knots. Namely the
use of cubic splines for modelling time dependent effects
was proposed by Hess, [29], allowing the study of possi-
ble covariate-time interactions without having to specify
a specific functional form, using a limited number of
parameters. The results are reported in Table 2.
In this simulation the Cox model with the correct spec-
ification of the time dependent effect of Z, that is log(t),
is used as benchmark estimation. When the time depen-
dence of Z is modelled using the restricted cubic spline,
the performance of the CGPM is less appealing, com-
pared to the benchmark, regarding all the parameters
considered into the simulation. The pseudo-value model
is really a competitor in this situation. It is in particular
interesting to observe the 95% confidence interval width.
The transformationmodel using pseudo-values with iden-
tity link is a valuable alternative to the CGPM when
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Table 2 Event times generated according to a
Cox-exponential model with a confounder X and an
exposure status Z with time-dependent effect
BIAS
√
MSE
PV Cox Cox PV Cox Cox
rcs(t) log(t) rcs(t) rcs(t) log(t) rcs(t)
200 -0.0290 0.0036 0.0151 0.0792 0.0689 0.1403
400 -0.0248 -0.0108 -0.0188 0.0730 0.0657 0.1119
600 -0.0185 -0.0134 -0.0242 0.0730 0.0657 0.1119
Width Coverage
PV Cox Cox PV Cox Cox
rcs(t) log(t) rcs(t) rcs(t) log(t) rcs(t)
200 0.2899 0.2700 0.5162 0.9270 0.9530 0.9120
400 0.2747 0.2528 0.4211 0.9470 0.9500 0.9170
600 0.2158 0.1860 0.3256 0.9410 0.9410 0.9300
The effect of Z is multiplied by log(t). CGPM was adopted using the Cox
proportional hazard regression model with the time dependent effect of Z
specified in two ways: (1) with an interaction between Z and log(t),
corresponding to the generating model; (2) with and interaction between Z and
a restricted cubic spline of time (rcs(t)). PV model was adopted with identity link.
Pseudo times were fixed at quantiles 5%, 25%, 50%, 75%, 95% of the failure time
distribution. The Z covariate was inserted with an interaction with the baseline
risk function modelled with a restricted cubic spline with 3 knots, giving an
estimated risk difference varying through follow-up time, RD(t).
the time dependent effect in the Cox model is unknown
and modelled using a flexible method. Model checking
is therefore very important and pseudo-values can be of
help also in this case, see the work of Anderson and
Perme, [46].
Prostate cancer
Literature data on 502 prostate cancer patients, pub-
licly available at the web site http://biostat.mc.vanderbilt.
edu/wiki/Main/DataSets, (Byar & Greene prostate cancer
data), treated with different doses of diethylstilbestrol in a
randomized clinical trial, [18], were used to estimate the
adjusted treatment effect (high versus low dose) on over-
all mortality. Seven covariates were used for adjustment,
namely: age (0,< 75 years; 1, 75− 80 years; 2, ≥ 80 years),
weight index (0, ≥ 100;1, 80 − 99; 2, < 80), performance
rating (0, normal; 1, limitation of activity), history of car-
diovascular disease (0, no; 1, yes), serum haemoglobin
(0, ≥ 12 g/100 ml; 1, 9-12 g/100 ml; 2, < 9 g/100 ml),
size of primary lesion (0, < 30 cm2; 1, ≥ 30 cm2), and
Gleason stage category (0, ≤ 10; 1, > 10). 483 patients
with complete information on the seven covariates avail-
able were considered. 344 patients died: 149 for cancer;
139 for cardiovascular causes; 56 for other causes.
The estimated RD(t) according to the CGPM using
a Cox proportional hazard model [14] is reported in
Figure 2. The estimated RD(t) is increasing through
follow-up time, from 1% to 5%. Correspondingly the
NNT(t) is about 100 at the beginning of the follow-
up time and about 17 after 6 years follow-up. The 95%
confidence interval is obtained using 2.5 and 97.5 per-
centiles of the bootstrap distribution of the estimated
RD(t) (1000 bootstrap resamples). The RD(t) confidence
interval includes 0.
The estimated RD(t) is based on a proportional hazard
model. In fact there is no evidence for time-dependent
treatment effect in Cox model according to Schoenfeld
residuals. However, Kay, [18], carefully investigated the fit
of the Cox model, dividing the time axis into three time
interval: [ 0−13]; (13−32]; (32−∞). The logHR for treat-
ment has a positive sign in the first period (0.09), then
becomes negative (−0.40 and −0.31). Comparing by like-
lihood ratio the model fitted on three intervals with an
overall survival model, evidence is found against the pro-
portional HR assumption. In fact, cardiovascular deaths
are more frequent than cancer deaths earlier during
follow-up while, later on, cancer deaths are prevalent.
Accordingly, the beneficial effect of treatment appears evi-
dent only after the first year of follow-up. The estimates
obtained with the CGPM appear therefore distorted due
to the use of a proportional hazard model.
As a model with jumps in covariate effects at specific
times is not biologically plausible, a Cox regression model
with an interaction between the treatment and a function
of time is used (specifically a B-spline with 1 interior knot
at the median of the failure time distribution). According
to the work of Hess, [29], splines are used tomodel flexibly
the possible treatment time dependent effect. The esti-
mated RD(t) according to this flexible model is reported
in Figure 2. The harmful initial treatment effect is not yet
captured.
A transformation model based on pseudo-values with
identity link is used to estimate a possibly time-dependent
treatment RD(t). In order to have about 10 events between
each pseudo consecutive times, 32 pseudo-times are con-
sidered at quantiles of the unique failure time distribution.
In this case B-splines are used to model the baseline
cumulative risk. One knot, placed at themedian of the fail-
ure time distribution, seems to be sufficient to model the
marginal survival function, see Figure 3.
A backward selection procedure is used to select the
time dependent effects for each covariate. The complete
model has a total of 45 degrees of freedom, including the 8
covariates and their time dependent effects. The selected
model exhibit a time dependent effect of history of cardio-
vascular disease, size of primary lesion and Gleason stage.
There is no evidence for a time dependent treatment
effect. The constant estimated RD is 2.2% with 95% con-
fidence interval [−3.5%; 7.9%]. The corresponding con-
stant estimate of NNT is about 45 patients to be treated
for one patient to benefit with 95% confidence interval
[−∞ to −28; 13 to ∞].
Ambrogi et al. BMCMedical ResearchMethodology 2014, 14:97 Page 9 of 14
http://www.biomedcentral.com/1471-2288/14/97
0 10 20 30 40 50 60 70
-
0.
10
-
0.
05
0.
00
0.
05
0.
10
0.
15
months
R
D
(t)
-
10
-
20
In
f
20
10
6.
67
N
N
T(
t)
Cox(3 intervals):
logHR = 0.09 logHR = -0.40 logHR = -0.31
Cox model: rxb proportional
Cox model: rxb time dependent
Pseudo-Values, Identity link, rxb by time interaction
0 20 40 60
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
months
su
rv
iv
al
high dose
low dose
Cox model:
rxb time dependent
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
60 40 20 0
Pseudo-values:
Identity link, rxb by time interaction
high dose
low dose
Figure 2 Prostate Cancer Trial: Treatment RD(t). Left: Estimate of treatment RD(t) and NNT(t) in the prostate cancer diethylstilbestrol trial by
different methods. Continuous line: CGPM with the Cox proportional hazard model. The estimated RD(t) is increasing through follow-up time.
Broken line: CGPM with a Cox model with a time dependent treatment effect (interaction treatment by time modeled with a B-spline with 1 knot at
the median of the failure time distribution). There is no treatment effect until month 20, then RD(t) increases until month 40. Dotted line: estimate
obtained using the transformation model with identity link. The RD(t) estimate is negative at the beginning of follow-up (harmful treatment) then
becomes positive after about 20 months (beneficial treatment) reflecting the differential impact on cardiovascular and cancer deaths. On the top:
three period Cox model used by Kay. The log hazard ratio is positive in the first period (0.09) [ 0 − 13], then becomes negative in the second (-0.40),
(13 − 32], and in the third (-0.31), (32 − ∞), periods. The three period model was preferred to the overall Cox model according to likelihood ratio,
accounting for non-proportional hazards. Right: estimated population averaged survival probability for the two intervention groups of the prostate
cancer trial. The estimate from the time-dependent Cox model is reported from left to the right. The estimate from the transformation model with
identity link is reported from right to the left. It is possible to observe a crossing of the survival curves.
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Figure 3Marginal Survival function. Estimate of the marginal survival function for the prostate cancer data using a transformation model
estimated with pseudo-values. 32 pseudo-times were considered. Each subject is therefore replicated 32 times in the dataset. The typical estimation
of the baseline risk function is through indicator variables. In this case 32 coefficients should be included in the model. A B-Spline was instead used
with one knot at the median of the unique failure time distribution resulting in 4 bases plus the intercept for modeling the baseline risk. The figure
shows the estimated marginal survival with superimposed the Kaplan-Meier estimate.
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It is interesting, however, to compare the RD(t)
estimated by the CGPM, which is by definition time
dependent, with the one estimated through the trans-
formation model letting the treatment effect varying in
time. The results are reported in Figure 2 and summarized
in Table 3. The treatment effect is harmful during the
first year, while the benefits appear afterwards in agree-
ment with the analysis of Kay [18] further refined using
competing risks.
In the right panel of Figure 2 are also reported the aver-
aged survival probabilities obtained by the CGPM using
the Cox model and the transformation model both with
the time-dependent effect of treatment. The plot of the
averaged survival probabilities is an important completion
of the RD(t) plot. In fact RD(t), as usual for the effect
measures, is reducing two numbers to a single number.
The prostate cancer data outline a scenario in which
the proportional hazard assumption for the treatment
effect is not tenable during all follow-up times. Data on
prostate cancer should be actually analyzed accounting
for competing risks. When a non competing risks sur-
vival analysis is performed, CGPM applied to the Cox
model without a time dependent treatment effect gives
an estimate of the RD(t) increasing during follow-up until
reaching a plateau. At the same time, the constant esti-
mate RD obtained using PV provides a distorted estimate
constant through follow-up. CGPM applied to the Cox
model with a time dependent treatment effect provides an
RD(t) estimate not yet capturing the initial harmful treat-
ment effect. The time-dependent estimate obtained from
the pseudo-value model is instead effective in describing
the treatment effect during follow-up time: harmful at the
beginning, when cardiovascular deaths are more frequent,
beneficial later on when cancer deaths are more frequent
Primary retroperitoneal soft tissue sarcoma
Retroperitoneal soft tissue sarcoma (STS) is an uncom-
mon disease. Histologic grade and completeness of
macroscopical resection are considered to be the major
prognosticators for survival, while histologic type, size
and age are more debated. One hundred and ninety two
patients with retroperitoneal STS admitted to National
Cancer Institute in Milan, consecutively, between 1985
and 2007 are considered. Patients are without evidence
of locoregional recurrence or distant metastasis. The
median follow-up is 54.8 moths (IQR: 25-104). Among the
192 patients included in the case series, 78 died during
follow-up. For a complete description of patients char-
acteristics see [19]. Kaplan-Meier Survival estimates for
resection margin and grading are reported in Figure 4.
The covariate resection margins is strongly unbalanced in
this case series. No evidence for time dependent covariate
effects is found using Schoenfeld residuals. A restricted
cubic spline with 3 knots, for a total of 2 bases, is used
to model the marginal transformed baseline cumulative
survival. The fit and the monotonicity of the estimated
baseline cumulative risk is controlled by visual inspection
[data not shown]. A backward procedure is used for time-
dependent covariate selection, fixing the significance at
a conservative 0.01 level. Using the cloglog link func-
tion, no evidence for time dependent effects is found.
Considering the log link, the effect of Grading appears
time-varying, while using the identity link, Grading and
resection margins are modelled varying in time. For the
sake of completeness, the estimates of the association
between resection margins and survival using the pseudo
value model and a cloglog link are compared with the
results from the Cox model. The cumulative constant HR
is 2.4 (95% CI: 1.38 − 4.31) with pseudo-values. Such an
association appears conservative compared to that esti-
mated through Cox regression: HR = 4.19 (95% CI:
2.04−8.59). In general it is possible to note an attenuation
of estimated effects using PV and the cloglog scale, com-
pared to the Cox model: in the case of resection margins
the attenuation is quite important. Clearly, the pseudo-
value model with cloglog link is of no interest in this
setting, while it has an interest for model checking in Cox
regression, [46].
Also the constant RR estimated using pseudo values and
log link appears conservative: RR = 1.3 (95% CI: 1.03 −
1.71). A comparison of the estimated RD(t) obtained
with pseudo values and identity link with the estimates
Table 3 RD(t) estimated with different methods at months 13, 32 and 60
RD
13 32 60
RD(t): Cox prop 3.7%; (−1.2%; 7.7%) 5.7%; (−1.2%; 12.3%) 5.8%; (−1.2%; 12.7%)
RD(t): Cox TD 0.1%; (−6.8%; 6.5%) 6.5%; (−1.5%; 14.1%) 7.7%; (−0.5%; 15.6%)
RD: PV identity Z const 2.2%; (3.5%;−7.9%) 2.2%; (3.5%;−7.9%) 2.2%; (3.5%;−7.9%)
RD(t): PV identity Z TD −1.6%; (−8.5%; 5.3%) 4.6%; (−3.2%; 12.4%) 6.2%; (−1.4%; 13.7%)
.
Cox prop: CGPM with a Cox model without treatment time dependent effect; Cox TD: CGPMwith a Cox model with treatment time dependent effect; PV identity Z
const: Pseudo-value model with identity link and constant treatment effect RD; PV identity Z TD: Pseudo-value model with identity link and time dependent treatment
effect. B-splines were used to model treatment time dependent effects
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Figure 4 Kaplan-Meier overall survival curves. Patients with retroperitoneal soft tissue sarcoma. Left panel: Surgical Margins. All patients
underwent surgery but some of them (14), especially those with advanced disease status, failed to have complete resection. Right panel: Grading
(1: 60; 2: 62; 3: 70).
obtained using the CGPM is reported in Figure 5.
Different averaging procedures are also reported. The
estimated RD(t) and point-wise confidence intervals using
the different methods are in close agreement. The dif-
ferent averaging procedures yield quite similar results in
this case. According to pseudo-values, the RD(t) reaches
a maximum value at 60 months and is about 40%.
According to Cox regression the HR of grading 2 vs 1 is
2.56 (1.27−5.16). The estimate obtained through pseudo-
values and cloglog link is 2.34 (1.27 − 4.32). There is still
an attenuation but not as huge as in the case of margins.
However, considering grading 3 vs 1 the attenuation effect
is more evident: theHR from Cox regression is 6.49 (3.31-
12.75), while using pseudo-values is 4.88 (2.54-9.39). The
RR(t) and RD(t) are reported in Figure 6. After 8 years the
RR(t) is 1.6 and 3.1, and the RD(t) is 36% and 59%, for 2
vs 1 and 3 vs 1 contrasts, respectively. Also in the case of
grading, the estimates obtained using pseudo-values and
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Figure 5 Retroperitoneal soft tissue sarcoma: Margins. RD(t) of extension of resection margins estimated using different methods. PV identity:
estimated effect using pseudo values, identity link and interaction between time and margins. Five pseudo times were used at times 6, 11, 23, 51, 96,
corresponding to quantiles 10%, 25%, 50%, 75%, 90% of the failure time distribution. CGPM: Corrected group prognosis method using a
proportional hazard Cox regression model. The averaging is performed on the whole sample of patients. Other two measures are reported: (1)
average over exposed: obtained averaging only on patients with macroscopic resection margins (EIN(t)); (2) average over unexposed: obtained
averaging only on patients without microscopic resection margins (NNE(t)).
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Figure 6 Retroperitoneal soft tissue sarcoma: Grading. The effect of the different Grading categories on the RR(t) and RD(t) scales are reported,
using different estimation methods. CGPM applied to a proportional hazard Cox model; PV with log and identiy links and interaction between time
and grading. The estimates obtained with the different techniques appears quite in agreement. No evidence for time dependent effects in the Cox
model was found.
those obtained using different averaging procedures from
the Cox regression model appear in good agreement. The
quantification of effects through risk differences may be
very important for the clinical management of the disease.
Discussion
In survival analysis the adjusted measure of association
everywhere adopted is the hazard ratio. Although the effi-
ciency of the hazard ratio makes it attractive for hypoth-
esis testing, it may not carry the most useful information
for clinicians/biostatisticians. Schechtman, [11], suggests
using also absolute measures in conjunction with relative
measures of covariate-outcome association. To provide
adjusted measures of association different from the haz-
ard ratio, a simple strategy is going through the calculation
of the predicted probabilities of event for an “average”
subject, the so called “average covariate method”. Such a
procedure estimates the measures of effect for an hypo-
thetical average subject and not population averaged
estimates. An alternative idea to provide adjusted sum-
mary measures of effect is the corrected group prognosis
method [27,28]. Extending this idea, using the concept
of counterfactuals, Laubender and Bender [13] proposed
methods for computing such population measures tak-
ing into account the confounder distribution. Bootstrap is
then used to obtain pointwise confidence intervals. Such
approaches are particularly appealing as they may adopt
the Cox regression model which is widely accepted in
medical literature.
However the Cox model may easily not be the best
regression procedure to be applied, simply because of
the assumption of proportional hazards. In fact, in pres-
ence of time dependent effects Cox regression may be
less appealing. This is demonstrated here through a sim-
ple simulation. When time-dependent effects in the Cox
model are specified using well-known flexible methods,
[29], without committing to a specific functional form, the
estimates are not optimal, especially in terms of efficiency.
In these circumstances the results of the simple simulation
presented here, suggest that the use of the pseudo-value
model may represent a valid alternative to the CGPM.
The simulation is not exhaustive and more work is needed
to fully understand the properties and the relationships
among the different estimation methods.
Considering a similar problem in the context of logis-
tic regression, Gehrmann and colleagues, [49], concluded
that the CGPM applied to logistic regression is the pre-
ferred method to estimate RD and NNT adjusted for
covariates compared to binomial, Poisson and linear
regression methods that directly estimates the RD (similar
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to pseudo-values with identity link) even if the fitted
response function differs from the true response function.
The context of time-to-event outcomes is more complex
than that of logistic regression especially for the problem
of time dependent effects. Whether similar results hold
for the Cox model has therefore to be further explored
thorough a series of simulation studies. In any case, when
using the CGPM, the basic model used to obtain event
probabilities during follow-up has to be adequate. This
means, for example, that the proportional hazard Cox
regression should not be applied if the proportional haz-
ard assumption is not satisfied.
In clinical literature, results of statistical analysis are
commonly reported in terms of regression coefficients
and their confidence intervals. Applied survival analysis
resorts entirely to the Cox model which is a particular
case of transformation models. Transformation models
include also the accelerated failure time models providing
a variety of measures of effects to be considered.
It is to be noted that, additive and multiplicative-
additive hazard regression models, [31] are not comprised
in this class. The estimated coefficients are differences of
hazard rates rather than ratios. These models were mainly
proposed to improve the fitting where the proportional
hazards model is not adequate or to check for propor-
tional hazard assumptions. Moreover, the measures of
impact provided are still based on hazards.
In this work a simple approach to obtain point and
interval estimates of association measures, by using trans-
formation models through suitable link functions, is pre-
sented. The general technique of estimation based on
pseudo-values proposed by Andersen and colleagues [43]
is used as it is simply implementable with standard soft-
ware.
Other techniques could have been considered to esti-
mate the transformation models. In this context, it is
of particular interest the estimate of the baseline sur-
vival function tomodel time dependent effects. Therefore,
semi-parametric techniques (see for example [50]) are not
of interest here. Maximum likelihood (ML) estimation can
however be conveniently used. Royston and Parmar pro-
posed ML for transformation models with cloglog and
logit links, [51], which are, however, the links of less inter-
est here.Moreover as the pseudo-value is defined between
the first and the last pseudo times (which are not the first
and last event times) it still makes sense to have a constant
RD model. In fact considering the whole follow-up time
interval, and especially the beginning of the follow-up,
RD(t) estimates should instead always be time-dependent.
From the methodological viewpoint, the only differ-
ence introduced in the presented examples with respect to
standard applications of the pseudo-valuemodel is the use
of spline functions to estimate the transformed baseline
survival. This modification is without practical efforts,
considered the wide availability of software to compute
spline bases. From the modeling point of view, care must
be paid to the monotonicity of the estimated transformed
baseline survival function. In general, provided the num-
ber of knots is limited, no problems of non monotonicity
were observed.
Another issue concerns the possible simultaneous use
of different association measures estimated through dif-
ferent link functions in a transformation model. In such
a case, practitioners must be aware that, due to lack
of power, not all time dependent effects can be cor-
rectly specified, and likely the different models cannot
hold simultaneously. In such a case, if different measures
are of interest, different models can be used simulta-
neously only if the results are in agreement with each
other.
From a theoretical point of view, cloglog and logit links
guarantee that the estimated probabilities are within the
range 0-1 but this is not guaranteed if log or identity links
are used with standard software. Research is in progress
to face this issue.
Conclusions
The use of different link functions in transformationmod-
els has been studied by several authors simply investigat-
ing the goodness of fit of the different links [40,41].
The alternative perspective considered here, evaluates
the use of different links with the goal of providing suitable
measures of association between covariates and outcome.
As a consequence, when a specific link function is chosen,
it should be expected the need to include time dependent
covariate effects into the model.
Transformation models estimated through pseudo-
values appear an easily implemented alternative to the
available approaches mainly based on Cox proportional
hazard model to obtain adjusted measures of association
eventually time-dependent also for continuous covariates.
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